From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Just how much financial trouble is broker Novum in and how did it manage to feck it up in this market?

By Tom Winnifrith | Thursday 6 August 2020


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Broker JubCap, whose financial woes we exposed here, is now in administration. It is an ex broker and not one that the world will miss. So who is next? Well, all the signs are that Novum, the bucket shop which employs king spiv Jon Bellis and has Gavin Burnell of Globo infamy working there even though he is not authorised to do so by the FCA, is in the merde. I suggested 66 days ago that its financials were so bad that the FCA needed to have a look and, for once, it seems the chocolate teapots have done more than that, acting on what I exposed. I count this as a win for the Sheriff so it’s ouzos all round at the Greek Hovel today.  But how is Novum in such a mess?

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:


Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 18:03:22